Date published: 2026-5-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

BPV Antibody (5091): sc-58094

2.0(1)
Write a reviewAsk a question

Datasheets
  • BPV Antibody (5091) is a mouse monoclonal IgG1 BPV antibody provided at 100 µg/ml
  • raised against BPV
  • recommended for detection of BPV by ELISA
  • At present, we have not yet completed the identification of the preferred secondary detection reagent(s) for BPV Antibody (5091). This work is in progress.
    Gene Editing Promo Banner

    QUICK LINKS

    SEE ALSO...

    BPV Antibody (5091) is a mouse monoclonal IgG1 antibody that detects the BPV protein of non-species reactive by enzyme-linked immunosorbent assay (ELISA). Anti-BPV antibody (5091) is available as the non-conjugated form, specifically designed to facilitate the study of bovine papillomavirus (BPV), which are small, non-enveloped viruses characterized by their icosahedral shape and circular double-stranded DNA genome. The BPV genome is divided into early and late regions, with the early region encoding nonstructural proteins E1 to E8, while the late region encodes structural proteins L1 and L2. Notably, the E2 protein plays a crucial role as the master regulator of papillomavirus transcription and replication, with its activity finely tuned through sequence-specific DNA binding. Understanding the function of the E2 protein is vital, as E2 not only orchestrates viral gene expression but also influences the viral life cycle and pathogenesis, making E2 a key target for therapeutic interventions. BPV is classified into six types, which are further divided into two subgroups, A and B; subgroup B viruses cause warts with a cauliflower-like appearance, predominantly affecting the head, neck, and shoulders in humans, while subgroup A viruses lead to cutaneous fibropapillomas that present as nodular lesions. BPV monoclonal antibody (5091) specificity and sensitivity make this reagent an essential tool for researchers investigating the molecular mechanisms of BPV infection and its associated diseases.

    For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.

    Alexa Fluor® is a trademark of Molecular Probes Inc., OR., USA

    LI-COR® and Odyssey® are registered trademarks of LI-COR Biosciences

    BPV Antibody (5091) References:

    1. Inhibition of the bovine papillomavirus E2 protein activity by peptide nucleic acid.  |  Kurg, R., et al. 2000. Virus Res. 66: 39-50. PMID: 10653916
    2. Monitoring and purification of proteins using bovine papillomavirus E2 epitope tags.  |  Kaldalu, N., et al. 2000. Biotechniques. 28: 456-60, 462. PMID: 10723557
    3. SOME PROPERTIES OF BOVINE PAPILLOMA VIRUS.  |  BOIRON, M., et al. 1964. Nature. 201: 423-4. PMID: 14110027
    4. Association of bovine papillomavirus E2 protein with nuclear structures in vivo.  |  Kurg, R., et al. 2005. J Virol. 79: 10528-39. PMID: 16051845
    5. A phosphorylation map of the bovine papillomavirus E1 helicase.  |  Lentz, MR., et al. 2006. Virol J. 3: 13. PMID: 16524476
    6. Studies on connective tissue tumors in the hamster produced by bovine papilloma virus.  |  Cheville, NF. 1966. Cancer Res. 26: 2334-9. PMID: 4289172
    7. Intracranial fibroblastic neoplasms in the hamster from bovine papilloma virus.  |  Robl, MG., et al. 1972. Cancer Res. 32: 2221-5. PMID: 4343012
    8. Genetic analysis of the bovine papillomavirus E2 transcriptional activation domain.  |  Breiding, DE., et al. 1996. Virology. 221: 34-43. PMID: 8661412
    9. Functional interaction of the bovine papillomavirus E2 transactivation domain with TFIIB.  |  Yao, JM., et al. 1998. J Virol. 72: 1013-9. PMID: 9444994

    Ordering Information

    Product NameCatalog #UNITPriceQtyFAVORITES

    BPV Antibody (5091)

    sc-58094
    100 µg/ml
    $322.00